With Option Care Deal Pending, Optum Makes Bid for Amedisys 

Posted June 16, 2023

Amedisys Inc. received an unsolicited proposal from the UnitedHealth Group subsidiary Optum to acquire all outstanding shares of the home health and hospice provider’s stock.

Amedisys, in its filing with the U.S. Securities and Exchange Commission (SEC) that Optum has proposed an all-cash transaction at $100 per share. This could represent a “superior proposal” compared to the company’s pending $3.6 billion deal with Option Care Health.

“On May 27, 2023, the Board determined that the unsolicited proposal received from Optum could reasonably be expected to result in an ‘Amedisys Superior Proposal’ as defined in Amedisys’ merger agreement with Option Care Health,” Amedisys wrote in the SEC filing.

Click here for the full article.

 

About Corridor

For over 30 years, Corridor has partnered with home health and hospice providers, delivering powerful solutions to support the unique challenges of caring for patients in the home. Our team of operations executives, clinicians, and nationally renowned industry experts have run provider organizations and resolved the same challenges you face. Contact us today to learn how we can help you.

To receive the most important industry updates, insights and news impacting home health and hospice, please make sure to sign up for our weekly newsletter.

Explore Corridor’s Solutions

Share This Story, Choose Your Platform!